BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2785211)

  • 1. Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist.
    Wilson AA; Dannals RF; Ravert HT; Frost JJ; Wagner HN
    J Med Chem; 1989 May; 32(5):1057-62. PubMed ID: 2785211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of acetylcholine on binding of 4-[125I]iododexetimide to muscarinic brain receptors.
    Weckesser M; Fixmann A; Holschbach M; Müller-Gärtner HW
    Nucl Med Biol; 1998 Nov; 25(8):777-80. PubMed ID: 9863566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterization of 4-[125I]iododexetimide binding to muscarinic cholinergic receptors in the rat heart.
    Matsumura K; Uno Y; Scheffel U; Wilson AA; Dannals RF; Wagner HN
    J Nucl Med; 1991 Jan; 32(1):76-80. PubMed ID: 1988640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosynthesis of [123I]N-methyl-4-iododexetimide and [123I]N-methyl-4-iodolevetimide: in vitro and in vivo characterisation of binding to muscarinic receptors in the rat heart.
    Kassiou M; Mardon K; Katsifis AG; Najdovski L; Dikic B; Mattner F; Lambrecht RM; Hicks RJ; Eu P; Loc'h C
    Nucl Med Biol; 1996 Feb; 23(2):147-53. PubMed ID: 8868287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo.
    Bakker G; Vingerhoets WA; van Wieringen JP; de Bruin K; Eersels J; de Jong J; Chahid Y; Rutten BP; DuBois S; Watson M; Mogg AJ; Xiao H; Crabtree M; Collier DA; Felder CC; Barth VN; Broad LM; Bloemen OJ; van Amelsvoort TA; Booij J
    J Nucl Med; 2015 Feb; 56(2):317-22. PubMed ID: 25593117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I-iododexetimide and single-photon emission computed tomography in epilepsy.
    Müller-Gärtner HW; Mayberg HS; Fisher RS; Lesser RP; Wilson AA; Ravert HT; Dannals RF; Wagner HN; Uematsu S; Frost JJ
    Ann Neurol; 1993 Aug; 34(2):235-8. PubMed ID: 8338348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of radiotracers for studying muscarinic cholinergic receptors in the living human brain using positron emission tomography: [11C]dexetimide and [11C]levetimide.
    Dannals RF; Långström B; Ravert HT; Wilson AA; Wagner HN
    Int J Rad Appl Instrum A; 1988; 39(4):291-5. PubMed ID: 2838435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of brain muscarinic acetylcholinergic receptors in living mice using a simple probe, [125I]-4-iododexetimide and [125I]-4-iodolevetimide.
    Sasaki M; Müller-Gärtner HW; Lever JR; Ravert HT; Dannals RF; Guilarte TR; Wagner HN
    Neuropharmacology; 1993 Dec; 32(12):1441-3. PubMed ID: 8152535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-123 N-methyl-4-iododexetimide: a new radioligand for single-photon emission tomographic imaging of myocardial muscarinic receptors.
    Hicks RJ; Kassiou M; Eu P; Katsifis AG; Garra M; Power J; Najdovski L; Lambrecht RM
    Eur J Nucl Med; 1995 Apr; 22(4):339-45. PubMed ID: 7607265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging muscarinic cholinergic receptors in human brain in vivo with Spect, [123I]4-iododexetimide, and [123I]4-iodolevetimide.
    Müller-Gärtner HW; Wilson AA; Dannals RF; Wagner HN; Frost JJ
    J Cereb Blood Flow Metab; 1992 Jul; 12(4):562-70. PubMed ID: 1618935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased ipsilateral [¹²³I]iododexetimide binding to cortical muscarinic receptors in unilaterally 6-hydroxydopamine lesioned rats.
    Knol RJ; de Bruin K; Opmeer B; Voorn P; Jonker AJ; van Eck-Smit BL; Booij J
    Nucl Med Biol; 2014 Jan; 41(1):90-5. PubMed ID: 24267055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.
    Claus JJ; Dubois EA; Booij J; Habraken J; de Munck JC; van Herk M; Verbeeten B; van Royen EA
    Eur J Nucl Med; 1997 Jun; 24(6):602-8. PubMed ID: 9169565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of extracellular acetylcholine on muscarinic receptor binding assessed by [125I]dexetimide and a simple probe.
    Sánchez-Roa PM; Wagner HN; Villemagne VL; London ED; Lever JR
    Eur J Pharmacol; 1998 Oct; 358(3):207-11. PubMed ID: 9822886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization and positron emission tomography evaluation of 4-[76Br]bromodexetimide and 4-[76Br]bromolevetimide for investigations of central muscarinic cholinergic receptors.
    Loc'h C; Kassiou M; Strijckmans V; Bottlaender M; Katsifis A; Schmid L; Mazière M; Lambrecht RM; Mazière B
    Nucl Med Biol; 1996 Apr; 23(3):235-43. PubMed ID: 8782231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of myocardial muscarinic receptors in streptozotocin-induced diabetic rats using iodine-123 N-methyl-4-iododexetimide.
    Mardon K; Kassiou M; Katsifis A; Najdovski L
    Eur J Nucl Med; 1999 Jul; 26(7):743-9. PubMed ID: 10398822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of partial volume correction on muscarinic cholinergic receptor imaging with single-photon emission tomography in patients with temporal lobe epilepsy.
    Weckesser M; Hufnagel A; Ziemons K; Griessmeier M; Sonnenberg F; Hackländer T; Langen KJ; Holschbach M; Elger CE; Müller-Gärtner H
    Eur J Nucl Med; 1997 Sep; 24(9):1156-61. PubMed ID: 9283110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biodistribution of two [18F]-labelled muscarinic cholinergic receptor ligands: 2-[18F]- and 4-[18F]-fluorodexetimide.
    Wilson AA; Scheffel UA; Dannals RF; Stathis M; Ravert HT; Wagner HN
    Life Sci; 1991; 48(14):1385-94. PubMed ID: 2008155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.
    Boundy KL; Barnden LR; Rowe CC; Reid M; Kassiou M; Katsifis AG; Lambrecht RM
    J Nucl Med; 1995 Jul; 36(7):1332-8. PubMed ID: 7790964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron labeled muscarinic acetylcholine receptor antagonist: 2- and 4-[18F]fluorodexetimide. Syntheses and biodistribution.
    Hwang DR; Dence CS; McKinnon ZA; Mathias CJ; Welch MJ
    Int J Rad Appl Instrum B; 1991; 18(2):247-52. PubMed ID: 2026502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
    Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
    Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.